Women exchange blows for vaccine shots
Khargone (MP), July 23: A fight erupted between groups of women who were waiting to get inoculated at a COVID-19 vaccination centre, which did not have enough vaccine doses, in Madhya Pradesh’s Khargone district, an official said on Friday.
A video of maskless women jostling and exchanging blows to get inoculated has gone viral on social media.
In the video of the incident that took place on Thursday, women are seen queuing up at a vaccination facility in Khal Bujar of Kasrawad tehsil, some 60 km from the district headquarters, when one of them tried to sneak into the facility. The video shows a woman being pushed, following which two groups of women are seen pulling each other’s hair and exchanging blows, even as a man is also seen trying to separate two women engaged in a fight.
When contacted, Khargone District Immunisation Officer Dr Sanjay Bhatt said more than 500 women turned up for vaccination at the centre, which only had 200 doses at its disposal. (PTI)
Tilak Nagar market in Delhi closed for protocol violations
New Delhi, July 23: Several markets in the Tilak Nagar area have been closed by the sub-divisional magistrate till July 27 following violations of Covid protocols, officials said on Friday.
Jitender Singh, the sub-divisional magistrate of Patel Nagar, on Thursday ordered the closure of Tilak Nagar markets comprising Mall road, main market, Mangal Bazar road, old market and fruit market area following reports of shopkeepers and customers not following Covid-appropriate behaviour. “It was reported that general public/shopkeepers of the market are not adhering to health protocol which may accelerate the Covid positivity rate in multiple ways and the market may be the hotspot in future for spreading COVID-19,” the order said. (PTI)
Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre
Hyderabad, July 23: Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
Speaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-based vaccine maker, said the companys facilities in four cities – Hyderabad, Bengaluru, Pune and Ankaleshwar – are currently producing Covaxin.
And it is still ongoing as we continue to manufacture, taking a commitment of more than 50 crore (500 million) of doses to be submitted to the government of India for its immunisation programme,” she said narrating the journey of Covaxin. Covaxin demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and65.2per centprotection against the B.1.617.2 Delta variant, Bharat Biotech said recently, while announcing the final analysis of the jab. (PTI)